MedTrace Logo

Technical Evaluation and Results of the Use of TREO® Modular Aortic Endografts for the Treatment of Abdominal Aortic Aneurysms

NCT06893952 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2025-03-25

No results posted yet for this study

Summary

This study is a clinical investigation as part of the post-market clinical follow-up of the TREO® abdominal aortic graft in its initial use, French, observational, multicenter, non-randomized, single-arm. Information on patient's health and the implanted device will be collected over a period of 5 consecutive years. The data collected will be analyzed on the technical success and the absence of major events (death, stroke, myocardial infarction, visceral ischemia, paraplegia, respiratory failure, renal failure, intraoperative blood loss, thromboembolic event) and possible reinterventions related to the patient's operation.

Conditions

  • Aortic Aneurysm Abdominal

Interventions

DEVICE

TREO Endograft

Post Market collection data in use of TREO modular endografts

Sponsors & Collaborators

  • Vascutek Ltd.

    lead INDUSTRY

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2025-04-30
Completion
2031-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06893952 on ClinicalTrials.gov